The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation

Thrombosis Research

Volumn 135, Issue 5, 2015, Pages 897-901

  Iba, Toshiaki ^a   Saitoh, Daizoh ^b   Gando, Satoshi ^c   Thachil, Jecko ^d  

^a JUNTENDO UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Anticoagulant agents; Antithrombin III; Consumption coagulopathies; Disseminated intravascular coagulation; Sepsis

Indexed keywords

ANTITHROMBIN; ANTITHROMBIN III;

ARTICLE; BILIARY TRACT INFECTION; BODY WEIGHT; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; GASTROINTESTINAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SUPPLEMENTATION; SURVIVOR; URINARY TRACT INFECTION; AGED; BLOOD CLOTTING; BLOOD CLOTTING TEST; COMPLICATION; DISSEMINATED INTRAVASCULAR COAGULATION; DRUG EFFECTS; FEMALE; MALE; METABOLISM; SEPSIS; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTITHROMBIN III; ANTITHROMBINS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; SEPSIS; TREATMENT OUTCOME;

EID: 84928625366     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.03.007     Document Type: Article

References (20)

1. G.T. Kinasewitz, S.B. Yan, B. Basson, P. Comp, J.A. Russell, and A. Cariou Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism Crit Care 8 2004 R82 R90
2. S. Gando, T. Kameue, S. Nanzaki, and Y. Nakanishi Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome Thromb Haemost 75 1996 224 228
3. F. Fourrier, C. Chopin, J. Goudemand, S. Hendrycx, C. Caron, and A. Rime Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies Chest 101 1992 816 823
4. K. Okabayashi, H. Wada, S. Ohta, H. Shiku, T. Nobori, and K. Maruyama Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit Am J Hematol 76 2004 225 229
5. J.F. Dhainaut, A.F. Shorr, W.L. Macias, M.J. Kollef, M. Levi, and K. Reinhart Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure Crit Care Med 33 2005 341 348
6. V. Pettilä, J. Pentti, M. Pettilä, O. Takkunen, and I. Jousela Predictive value of antithrombin III and serum C-reactive protein concentration in critically ill patients with suspected sepsis Crit Care Med 30 2002 271 275
7. T. Iba, A. Kidokoro, M. Fukunaga, K. Sugiyama, and H. Kato Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers Shock 23 2005 25 29
8. M. Sivula, M. Tallgren, and V. Pettilä Modified score for disseminated intravascular coagulation in the critically ill Intensive Care Med 31 2005 1209 1214
9. T. Tagami, H. Matsui, H. Horiguchi, K. Fushimi, and H. Yasunaga Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study J Thromb Haemost 12 2014 1470 1479
10. T. Iba, S. Saito, H. Wada, and H. Asakura Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: A prospective multicenter survey Thromb Res 130 2012 e129 e133
11. T. Iba, D. Saitoh, H. Wada, and H. Asakura Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: A secondary survey Crit Care 18 2014 497
12. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definition for sepsis and organ failure and guidelines for the use innovative therapies in sepsis Crit Care Med 20 1992 864 874
13. S. Gando, T. Iba, Y. Eguchi, Y. Ohtomo, K. Okamoto, and K. Koseki A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria Crit Care Med 34 2006 625 631
14. B.L. Warren, A. Eid, P. Singer, S.S. Pillay, P. Carl, and I. Novak Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial JAMA 286 2001 1869 1878
15. R.P. Dellinger, M.M. Levy, A. Rhodes, D. Annane, and H. Gerlach Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 Intensive Care Med 39 2013 165 228
16. J. Kienast, M. Juers, C.J. Wiedermann, J.N. Hoffmann, H. Ostermann, and R. Strauss Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation J Thromb Haemost 4 2006 90 97
17. C.J. Wiedermann, and N.C. Kaneider A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis Blood Coagul Fibrinolysis 17 2006 521 526
18. H. Wada, H. Asakura, K. Okamoto, T. Iba, T. Uchiyama, and K. Kawasugi Expert consensus for the treatment of disseminated intravascular coagulation in Japan Thromb Res 125 2010 6 11
19. S. Gando, D. Saitoh, H. Ishikura, M. Ueyama, Y. Otomo, and S. Oda A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis Crit Care 17 2013 R297
20. A. Sawamura, S. Gando, M. Hayakawa, H. Hoshino, N. Kubota, and M. Sugano Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness Clin Appl Thromb Hemost 15 2009 561 566